2024-11-14T20:42:50-06:00 2023-12-31 872729353 CNACPA PC 15105 CONCORD CIR 130 MORGAN HILL CA 95037 990 2023-01-01 113800306 FOGARTY INSTITUTE FOR INNOVATION FOGA 6509624560 2495 HOSPITAL DRIVE 300 MOUNTAIN VIEW CA 94040 GAYLE KUOKKA CFO 6509624560 2024-11-14 1 0 SHELDON CHAVAN P01001593 4087762401 2023 2024-10-15 13:58:12Z ANDREW CLEELAND 2495 HOSPITAL DRIVE 300 MOUNTAIN VIEW CA 94040 2939436 0 X WWW.FOGARTYINSTITUTE.ORG X 2006 CA THE FOGARTY INSTITUTE FOR INNOVATION IS DEDICATED TO FINDING NEW WAYS TO TREAT ILLNESSES AND IMPROVE THE WELL-BEING OF PATIENTS THROUGH THE PRACTICAL APPLICATION OF INNOVATIVE IDEAS AND THE EDUCATION AND MENTORING OF MEDICAL INNOVATORS. 10 9 37 100 0 0 10354048 178952 1571138 2186203 45007 574281 633766 0 12603959 2939436 142000 38600 0 0 4627557 5076403 0 0 155446 2381201 2515778 7150758 7630781 5453201 -4691345 26940908 21350391 12196466 11020749 14744442 10329642 X THE FOGARTY INSTITUTE FOR INNOVATION IS DEDICATED TO FINDING NEW WAYS TO TREAT ILLNESSES AND IMPROVE THE WELL-BEING OF PATIENTS THROUGH THE PRACTICAL APPLICATION OF INNOVATIVE IDEAS AND THE EDUCATION AND MENTORING OF MEDICAL INNOVATORS. 0 0 4290051 10000 1971951 INNOVATION PROGRAM - FOR DECADES, THE UNITED STATES HAS BENEFITED FROM BEING HOME TO THE PRE-EMINENT MEDICAL INNOVATION ECOSYSTEM IN THE WORLD. THIS HAS ENSURED SUCCESS TO CUTTING-EDGE TREATMENT OPTIONS FOR THE NATION'S CITIZENS, HAS FUELED THE ECONOMY BY BEING A MAJOR DRIVER OF SMALL BUSINESS AND JOB CREATION, AND HAS REPRESENTED A SIGNIFICANT AND CRITICAL COMPONENT OF THE NATION'S OVERALL GLOBAL TECHNOLOGICAL LEADERSHIP. THE ULTIMATE GOAL OF THE 501(C)(3) NON-PROFIT FOGARTY INSTITUTE FOR INNOVATION IS TO SUPPORT MEDICAL INNOVATION TO BENEFIT PATIENTS. AS A NECESSARY CONSEQUENCE OF THIS EFFORT, THE INSTITUTE ADDRESSES THE FACTORS THREATENING THE NATION'S MEDICAL INNOVATION ECOSYSTEM HEAD-ON.THE UNIQUE APPROACH OF THE INSTITUTE IS TO IDENTIFY INNOVATIONS THAT HAVE ESPECIALLY HIGH POTENTIAL FOR PATIENT BENEFIT. THROUGH ITS FLAGSHIP INNOVATION SUPPORT PROGRAM, THE FOGARTY INSTITUTE RECEIVES APPLICATIONS FOR SUPPORT FROM A BROAD CANDIDATE POOL THAT INCLUDES PHYSICIANS, STUDENTS, ENGINEERS, AND ENTREPRENEURS. INNOVATIONS HAVING THE GREATEST POTENTIAL FOR PATIENT BENEFIT ARE SELECTED, AND THE INSTITUTE SUPPORTS THE INNOVATOR'S EFFORTS TO DELIVER THEIR INNOVATIONS TO PATIENTS. THE TYPES OF SUPPORT PROVIDED TO SELECTED INNOVATORS BY THE INSTITUTE INCLUDE (A) DIRECT MENTORING BY OTHER MEMBERS OF THE MENTOR STAFF IN THE PROCESS OF MEDICAL INNOVATION AND DEVELOPMENT, (B) SIGNIFICANT, ACCESS TO EL CAMINO HOSPITAL PHYSICIANS AND FACILITIES THAT PROVIDES INNOVATORS WITH INVALUABLE INFORMATION THAT GUIDES MEDICAL TECHNOLOGY DEVELOPMENT, (C) LABORATORY/ENGINEERING SPACE, (D) FINANCIAL AID, AND (E) ACCESS TO THE INSTITUTE'S NETWORK OF FUNCTIONAL EXPERTS.THE INSTITUTE'S LAB SPACE IS CURRENTLY DEVOTED TO THE DEVELOPMENT OF MEDICAL TECHNOLOGIES THAT ADDRESS A RANGE OF CONDITIONS, AND THESE INCLUDE NOT LIMITED TO MATERNAL AND INFANT HEALTH, CARDIOVASCULAR DISEASE, AND A VARIETY OF DIAGNOSTIC TOOLS. 1954528 28600 214252 EDUCATION PROGRAM - THROUGH ITS EDUCATION PROGRAM, THE FOGARTY INSTITUTE MAKES ITS UNIQUE MENTORING CAPABILITY AVAILABLE TO A MUCH LARGER AUDIENCE THAN IS POSSIBLE WITH THE INNOVATION SUPPORT PROGRAM BY PROVIDING WORKSHOPS, SEMINARS AND INTERNSHIPS TO INTERESTED MEMBERS OF THE MEDICAL INNOVATION, CLINICIAN, AND ENTREPRENEUR COMMUNITIES. IN THIS WAY, WE HOPE TO NOT ONLY SUPPORT ACTIVE INNOVATORS, BUT ALSO INSPIRE THE NEXT GENERATION OF MEDICAL INNOVATORS SUCH AS COLLEGE AND HIGH SCHOOL STUDENTS WHO MAY BE CONSIDERING A CAREER IN MEDICAL INNOVATION. 6244579 1 1 0 0 0 0 0 0 0 0 1 1 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 18 0 1 37 1 0 0 0 0 0 0 0 0 0 0 X 10 9 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 CA X GAYLE KUOKKA 6502188733 2495 HOSPITAL DRIVE SUITE 300 MOUNTAIN VIEW CA 94040 THOMAS FOGARTY MD FOUNDER/DIRECTOR 2.00 X 0 0 0 THOMAS M KRUMMEL MD CHAIRMAN 2.00 X 0 0 0 FREDERICK ST GOAR MD VICE CHAIRMAN 2.00 X 0 0 0 J CASEY MCGLYNN JD DIRECTOR 2.00 X 0 0 0 LEWIS WEXLER MD DIRECTOR 2.00 X 0 0 0 ALLAN R WILL DIRECTOR 2.00 X 0 0 0 ANDREW CLEELAND CEO 40.00 X X 290372 0 40934 STACY ENXING-SENG DIRECTOR 2.00 X 0 0 0 ANGELA MACFARLANE DIRECTOR 2.00 X 0 0 0 MARK LEAHEY DIRECTOR 2.00 X 0 0 0 GAYLE KUOKKA CFO 40.00 X 309547 0 43293 MARGA ORTIGAS-WEDEKIND CHIEF STRATEGY OFFICER 40.00 X 330057 0 40211 DENISE ZARINS CHIEF OPERATING OFFICER 40.00 X 305250 0 27934 MICHAEL REGAN CHIEF OPERATING OFFICER 40.00 X 328493 0 22097 ALLIE GREGORIAN CHIEF ALLIANCE OFFICER 40.00 X 259625 0 1261 JOHN MORRISS DIRECTOR OF INVENTION 40.00 X 284650 0 14433 2107994 0 190163 7 0 1 0 ZACHARY EDMONDS MD 250 GRANT ROAD MOUNTAIN VIEW CA 94040 RESEARCH 116589 1 178952 178952 SPONSORED ACCESS FEE 900099 1481631 1481631 CIR ACCESS FEE 900099 690320 690320 REGISTRATION FEE 900099 14252 14252 2186203 573709 573709 572 0 572 572 572 2939436 2186203 0 574281 38600 38600 4154217 3236321 784610 133286 671210 537685 122896 10629 250976 193456 50553 6967 20525 19775 750 42000 42000 500953 429387 71456 110 62148 57307 4829 12 1315921 1240741 71756 3424 64391 59550 4654 187 136712 113471 23241 34515 34515 OTHER 174401 168881 5384 136 DUES AND SUBSCRIPTIONS 115847 102205 13000 642 EQUIPMENT RENTAL 48365 47200 1112 53 7630781 6244579 1230756 155446 7627533 213051 5000000 5000000 422349 464679 172498 236886 2004233 746822 1394122 1257411 128995 2864006 2402233 2664198 9793178 8650160 26940908 21350391 41025 166815 145743 40896 1121586 1165603 1283659 1208585 9604453 8438850 12196466 11020749 X 9060450 4694978 5683992 5634664 14744442 10329642 26940908 21350391 X -4691345 261965 14580 X 0 1 X 1 0 X 384655 565232 249350 319048 178952 1697237 384655 565232 249350 319048 178952 1697237 1697237 57193 1682 5258 35479 573709 673321 2370558 0.71600 0.78650 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1450700 341208 1109492 244861 241572 3289 308672 164042 144630 1257411 2664198 F 2664198 INTEREST IN CHARITABLE REMAINDER TRUST 387754 DEPOSITS 108002 OPERATING RIGHT-OF-USE ASSET 8154404 8650160 OPERATING LEASE LIABILITY 8438850 8438850 X 3246067 261965 28461 16205 306631 2939436 0 2939436 7660867 28461 1625 30086 7630781 0 7630781 PART X, LINE 2: THE INSTITUTE BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN TO DATE AND, THEREFORE, HAS NO RELATED INCOME TAX DUE FOR ALL YEARS WHERE THE STATUTE OF LIMITATIONS REMAINS OPEN. AS A RESULT, NO PROVISION FOR FEDERAL OR STATE INCOME TAXES HAS BEEN MADE IN THE ACCOMPANYING CONSOLIDATED FINANCIAL STATEMENTS. PART XI, LINE 2D - OTHER ADJUSTMENTS: CHANGE IN VALUE - CHARITABLE REMAINDER TRUST 15,742. SUBSIDIARY INCOME 463. PART XII, LINE 2D - OTHER ADJUSTMENTS: SUBSIDIARY EXPENSES 1,625. 0 STANFORD UNIVERSITY 485 BROADWAY MAIL CODE 8838 REDWOOD CITY CA 94063 941156365 10000 0 GIFT TO THE TRACY LEFTEROFF MEMORIAL LECTURE FUND PART I, LINE 2: THROUGH ITS ON-LINE APPLICATION PROCESS, AND RIGOROUS PHYSICIAN-DRIVEN REVIEW PROCESS, THE FOGARTY INSTITUTE SELECTS THE VERY BEST MEDICAL INNOVATIONS - THOSE HAVING THE GREATEST POTENTIAL TO BENEFIT PATIENTS. APPLICATIONS FOR SUPPORT COME FROM A BROAD CANDIDATE POOL THAT INCLUDES PHYSICIANS, STUDENTS, ENGINEERS, NURSES, AND ENTREPRENEURS. ONCE THEY BEGIN THEIR RESIDENCE AT THE INSTITUTE, INNOVATORS MEET REGULARLY - TYPICALLY TWICE PER MONTH - WITH A DESIGNATED INSTITUTE POINT-OF-CONTACT TO REVIEW PROGRESS TOWARDS AGREED UPON MILESTONES. ADDITIONALLY, INNOVATORS REPORT TO THE FULL INSTITUTE LEADERSHIP WHILE RESIDING AT THE INSTITUTE. IN THESE WAYS, INNOVATOR PROGRESS AND USE OF GRANT FUNDS ARE MONITORED. IF PROGRESS WITHIN A REASONABLE AMOUNT OF TIME IS DEEMED INADEQUATE, OR USE OF FUNDS INAPPROPRIATE, THE SUPPORTED PROGRAM IS TERMINATED, AND FUNDS AND RESOURCES ARE RE-DIRECTED. GRANTS PROVIDED IN SUPPORT OF INNOVATION PROJECTS OR EVENTS REQUIRE THE INNOVATOR PROJECT TEAM TO PROVIDE UPDATES TO INSTITUTE LEADERSHIP APPROXIMATELY ONCE PER QUARTER, OR AS NEEDED, REGARDING PROJECT MILESTONES, DEVIATIONS FROM TIMELINE, AND UN-ANTICIPATED CHALLENGES. X X 0 0 0 0 0 0 0 0 0 MARGA ORTIGAS-WEDEKIND CHIEF STRATEGY OFFICER 330057 0 0 0 0 0 0 0 40211 0 370268 0 0 0 GAYLE KUOKKA CFO 309547 0 0 0 0 0 0 0 43293 0 352840 0 0 0 MICHAEL REGAN CHIEF OPERATING OFFICER 328493 0 0 0 0 0 0 0 22097 0 350590 0 0 0 DENISE ZARINS CHIEF OPERATING OFFICER 305250 0 0 0 0 0 0 0 27934 0 333184 0 0 0 ANDREW CLEELAND CEO 290372 0 0 0 0 0 0 0 40934 0 331306 0 0 0 JOHN MORRISS DIRECTOR OF INVENTION 284650 0 0 0 0 0 0 0 14433 0 299083 0 0 0 ALLIE GREGORIAN CHIEF ALLIANCE OFFICER 259625 0 0 0 0 0 0 0 1261 0 260886 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B A DRAFT OF THE 990 IS REVIEWED BY THE CFO PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD REVIEWS THE CONFLICT OF INTEREST POLICY ON AN ANNUAL BASIS AND INQUIRES OF THE BOARD MEMBERS AS TO THE EXISTENCE OF RELATIONSHIPS OR TRANSACTIONS THAT COULD GIVE RISE TO CONFLICT. FORM 990, PART VI, SECTION B, LINE 15 OFFICER'S AND KEY EMPLOYEE'S COMPENSATION IS REVIEWED AND APPROVED BY THE BOARD OF DIRECTORS. THE REVIEW PROCESS INVOLVES APPROVAL BY INDEPENDENT PERSONS, REVIEW OF COMPARABLE DATA, AND SUBSTANTIATION OF DELIBERATIONS. FORM 990, PART VI, SECTION C, LINE 18 COPIES OF FORM 990 ARE AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART VI, SECTION C, LINE 19 THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART XI, LINE 9: CHANGE IN RESIDUAL TRUST 15,742. SUBSIDIARY NET LOSS -1,162. FOGARTY CLINICAL RESEARCH INC 2495 HOSPITAL DRIVE SUITE 300 MOUNTAIN VIEW CA 94040 451670017 CLINICAL RESEARCH CA FOGARTY INSTITUTE FOR INNOVATION C -1162 48953 1.00000 1 CHARITABLE REMAINDER TRUSTS 2490 HOSPITAL DRIVE MOUNTAIN VIEW CA 94040 TRUST CA FOGARTY INSTITUTE FOR INNOVATION T 1.00000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0